Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Friday, December 5, 2008, 11:14AM ET - U.S. Markets close in 4 hours and 46 minutes. Dow Down 2.06% Nasdaq Down 1.56%
AngioDynamics Inc. (ANGO)At 10:54AM ET: 9.70  Down 0.40 (3.96%)  
MORE ON ANGO
Quotes
Charts
News & Info
Company
HereProfile
Analyst Coverage
Ownership
Financials

ProfileGet Profile for:
AngioDynamics Inc.
603 Queensbury Avenue
Queensbury, NY 12804
United States - Map
Phone: 518-798-1215
Fax: 518-798-3625
Web Site: http://www.angiodynamics.com

DETAILS 
Index Membership:N/A
Sector:Healthcare
Industry:Medical Instruments & Supplies
Full Time Employees:566

BUSINESS SUMMARY 
AngioDynamics, Inc. designs, develops, manufactures, and markets various therapeutic and diagnostic devices that enable interventional physicians to treat peripheral vascular disease, tumors, and other non-coronary diseases. It offers various interventional product lines, such as angiographic, dialysis, vascular access, venous, thrombolytic, PTA, and drainage. The company’s angiographic product line comprises angiographic catheters, entry needles, guidewires, and fluid management products. Its dialysis product line includes SCHON, EVENMORE, Centros, DURA-FLOW, SCHON XL, DYNAMIC FLOW, and CIRCLE C to treat acute renal failure, chronic renal failure, and end-stage renal disease. The company’s vascular access product line consists of MORPHEUS CT PICC, micro access sets, transjugular access set, specialty access ports, Vortex line of ports, the LifeGuard safety infusion set, the LifeGuard Vision, Neostar tunneled central venous catheters, and LifeValve Platinum central venous catheter. Its venous product line includes VenaCure and Sotradecol products; thrombolytic product line comprises PULSE SPRAY, UNI FUSE, and SPEEDLYSER catheters; PTA product line consists of PTA dilation balloon catheters, including WORKHORSE and PROFILER to open blocked blood vessels and dialysis access sites; and drainage product line includes TOTAL ABSCESSION general drainage catheters. Further, the company offers various oncology product lines, including radio-frequency ablation, tumor embolization, laparoscopic resection, and NanoKnife to provide a minimally invasive approach to ablating solid cancerous or benign tumors. It offers its products to interventional radiologists, vascular surgeons, and surgical oncologists through a direct sales force in the United States and through a combination of direct sales and distributor relationships internationally. The company, formerly known as A.D., Inc., was founded in 1988 and is headquartered in Queensbury, New York.
Key Statistics

COMPANY WEBSITES 
  • Home Page
  • Search Yahoo! for:
    More on AngioDynamics Inc.


    CORPORATE GOVERNANCE 
    AngioDynamics Inc.'s Corporate Governance Quotient (CGQ®) as of 1-Dec-08 is better than 68% of Russell 3000 companies and 68.9% of Health Care Equipment & Services companies.
    Brought to you by Institutional Shareholder Services.

    KEY EXECUTIVES 
     PayExercised
    Mr. Eamonn Hobbs , 50
    Chief Exec. Officer, Pres
    $ 458.00K $ 1.53M
    Mr. D. Joseph Gersuk , 57
    Chief Financial Officer, Chief Accounting Officer, Exec. VP and Treasurer
    $ 351.00KN/A
    Mr. Harold C. Mapes , 48
    Sr. VP of Operations
    $ 240.00KN/A
    Mr. Robert M. Rossell , 52
    Sr. VP and Gen. Mang. of Access Division
    N/A N/A
    Mr. William M. Appling , 45
    Sr. VP of Advanced Research
    N/A N/A
    Dollar amounts are as of 31-Dec-08 and compensation values are for the last fiscal year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of options exercised during the fiscal year.
    View Insiders


    Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
    Get Profile for Another Symbol: Symbol Lookup
    Annual ReportsSector Analysis